Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Invitrogen
Lincomycin Recombinant Mouse Monoclonal Antibody (3F6)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Lincomycin Antibody (MA566435) in SDS-PAGE
SDS-PAGE characterization of Lincomycin under reducing conditions. Lane M: Protein marker (kDa); Lane LM: Purified Lincomycin Recombinant Monoclonal (Product # MA566435). Lincomycin showing heavy chain (~50 kDa) and light chain (~25 kDa). Gels were stained with Coomassie Brilliant Blue R-404.
产品信息
MA566435
产品规格
种属反应
Chemical
宿主/亚型
Mouse
/ IgG
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
克隆号
3F6
抗原
Conjugate of LM hapten and KLH.
偶联物
形式
Liquid
浓度
7.3 mg/mL
纯化类型
Protein G
保存液
PBS
内含物
0.09% sodium azide
保存条件
-20°C
运输条件
Ambient (domestic); Wet ice (international)
靶标信息
Lincomycin is a naturally occurring antibiotic produced by the actinomycete Streptomyces lincolnensis, effective against Gram-positive bacteria and protozoans. It was first isolated in Lincoln, Nebraska, and belongs to the lincosamide group of antibiotics, characterized by a chemical structure consisting of amino acid and sugar moieties. The biosynthesis of lincomycin involves the creation of an unusual eight-carbon aminosugar, which is then functionalized with diverse l-proline derivatives and sulfur appendages. The MarR family transcriptional regulator LcbR2 has been identified as an activator of lincomycin biosynthesis, enhancing its production. Lincomycin A and its semisynthetic analogue, clindamycin, are used in clinical settings due to their unique structures and remarkable biological activities.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
